A Study of 1592U89 in HIV-Infected Adults

NCT00002200 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: Abacavir sulfate

Sponsor

Glaxo Wellcome